Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Abbott Provides the Right Laboratory Solutions for Imperial College Healthcare

Published: Friday, November 30, 2012
Last Updated: Friday, November 30, 2012
Bookmark and Share
Abbott’s managed service contract provides trusts with a cost-effective, guaranteed service.

The Division of Infection and Immunity at Imperial College Healthcare NHS Trust is benefitting from a managed service contract with Abbott, ensuring an efficient and reliable service for one of Britain’s largest NHS trusts.

Consultant Virologist Mark Atkins explained: “The Trust has a catchment of almost 1.5 million people, and so it is vital that all our equipment functions as it should, or a backlog will quickly develop. We have been working with Abbott for many years, and we know we can rely on our ARCHITECT® platforms and other Abbott instruments to perform as expected. The full automation offered by these systems gives us the throughput and flexibility to deliver a high quality, efficient service for our clinicians; the lab simply wouldn’t work without them.”

“The benefits of our managed service contract were clearly demonstrated during the recent merger of microbiology, virology and immunology services into a single blood sciences group within the Trust. Our Abbott facilities manager was instrumental in this, co-ordinating the transfer of equipment so that it did not interrupt services or have an impact on patients. The Abbott team also helped us to develop more efficient combined workflows, listening to our needs and delivering solutions that matched our requirements. For example, we are now running syphilis assays on our ARCHITECT systems, meaning all antenatal samples can be run on a single analyzer, and we can also run a high performance HIV test on this platform.”

Rebecca Stalham, Marketing and Contracts Director at Abbott, added: “A managed service contract provides trusts with a cost-effective, guaranteed service, allowing laboratory staff to focus on high value work which ultimately leads to better patient care, and we are happy that this model is working so well for Imperial College Healthcare.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
Developing Drug Resistance may be a Matter of Diversity for Tuberculosis
Researchers have probed the bacteria that causes tuberculosis, Mycobacterium tuberculosis, to learn more about how individual bacterial cells change and adapt while in the human body.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
Some Gut Microbes May Be Keystones of Health
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
Essential Component of Antiviral Defense Identified
Infectious disease researchers at the University of Georgia have identified a signaling protein critical for host defense against influenza infection.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Is Allergy the Price We Pay for Our Immunity to Parasites?
New findings help demonstrate the evolutionary basis for allergy.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
Mucus – the First Line of Defence
Researchers reveal the important role of mucus in building a good defence against invaders.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos